Results per Page:
Small cell lung cancer research gets a boost
Drs. David MacPherson and Gavin Ha receive $1.5M from Andy Hill CARE Fund to create much-needed liquid biopsy for SCLC
Let cancer eat cake
Fred Hutch study finds that feeding NRF2-mutated tumors too much of a nutrient they crave makes them vulnerable to slower growth and cell death
Reprogramming pancreatic cancer to become more treatment responsive
From the Kugel Lab, Human Biology Division
Targeting oncogenic TRK fusion proteins for disposal
From the Nabet Lab and Holland Lab, Human Biology Division
Fred Hutch Cancer Center announces 2026 Evergreen Fund awardees
Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential
Two Fred Hutch postdocs receive prestigious Damon Runyon awards
The early-career scientists will study the biology of acute myeloid leukemia and how certain treatments can make immunocompromised cancer patients more vulnerable to lung infections
Mapping how translational machinery shapes lineage determination in prostate cancer
From the Hsieh Lab, Human Biology Division
Beyond neutralization: the secret life of ADCC antibodies
From the Overbaugh Lab, Human Biology Division
Fred Hutch names 8 recipients of the Dr. Eddie Méndez Award
Annual award celebrates early-career scientists’ research in cancer, infectious disease and basic sciences
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better
Las condiciones precancerosas hacen que el estómago sea susceptible a infecciones bacterianas
Del Laboratorio Salama, Departamento de Biología Humana
Evolution of a stomach bug: Helicobacter pylori sticks around to survive
From the Salama Lab, Human Biology Division
Boosting CAR-T cell endurance to take on solid tumors
From the Srivastava Lab, Human Biology Division
Fred Hutch study dramatically expands therapeutic range of approved kinase drugs
Large-scale analysis reveals new uses for existing therapies across cancer types and non-cancer diseases
Fred Hutch brings together rare cancer community
Patients and caregivers share frustrations, practical realities of rare cancer life at TRACER program’s first education symposium
Fred Hutch collaboration reveals molecular vulnerability in rare childhood brain cancer
Researchers uncover a weak link in tumors driven by a notorious gene fusion that could be targeted with a drug
Giving CAR T cells a portable pit crew
Fred Hutch scientists dig deep into the biology of CAR T-cell exhaustion and examine experimental strategy to improve the immunotherapy for solid tumors